In recent decades, the global medical community has grown accustomed to a familiar narrative regarding pediatric cholelithiasis—the presence of gallstones in children. Traditionally associated with rare metabolic or congenital anomalies, the surging incidence of pediatric gallbladder disease has been predominantly blamed on the modern rise of childhood obesity and sedentary lifestyles. Consequently, when a child presents with abdominal pain, nausea, and jaundice, clinicians frequently evaluate for metabolic syndrome, dietary factors, or incidental findings on widespread abdominal ultrasonography.
However, a newly published clinical case report in Frontiers in Hematology (August 2026) serves as a sharp reminder that metabolic explanations should not entirely eclipse other causes. Chronic hemolytic disorders—conditions where red blood cells are destroyed prematurely—remain a significant and frequently underrecognized driver of pediatric gallstones, accounting for roughly 5% to 20% of cases. When these disorders manifest in mild or compensated forms, they can completely bypass standard clinical radar.
The report details the compelling case of a 7-year-old girl whose seemingly routine presentation of biliary disease acted as the opening act for a previously undiagnosed, life-threatening hematologic condition: hereditary spherocytosis. Moving swiftly from emergency department admission to acute biliary pancreatitis, her clinical course highlights a dangerous diagnostic pitfall. Standard blood counts can easily appear deceptively normal, masking an underlying process of red blood cell destruction. To combat this diagnostic blind spot, the authors have introduced a novel, structured clinical flowchart designed to help pediatricians, general practitioners, and surgeons spot subtle hematological "red flags" early, ensuring timely referrals and preventing catastrophic complications.
Detailed Chronology: From Emergency Admission to Definitive Diagnosis
The clinical journey of the 7-year-old patient underscores how rapidly a seemingly isolated gastrointestinal complaint can escalate into a medical emergency.
Presentation and Initial Findings
The patient, a young girl with a normal body mass index (ruling out the typical obesity-driven pathway for pediatric gallstones), presented to the emergency department experiencing acute, sharp abdominal pain, persistent vomiting, and noticeable jaundice. A review of her medical history revealed a past bout of neonatal hemolytic jaundice, though her family history was completely devoid of known hematologic disorders. She had no history of recent travel to regions with endemic parasitic infections, nor had she taken any chronic medications or antibiotics—such as ceftriaxone—that are known to cause biliary sludge.
A physical examination confirmed generalized jaundice, localized tenderness in the right upper quadrant of the abdomen, and mild splenomegaly (enlarged spleen). Initial laboratory evaluations revealed a complex picture:
- Blood counts were deceptively near normal (hemoglobin at 12.3 g/dL).
- Liver enzymes and indirect bilirubin were markedly elevated.
- Pancreatic enzymes showed mild elevation.
- The patient’s urine was notably cola-colored, a classic warning sign of hemoglobinuria caused by free circulating hemoglobin from broken-down red blood cells.
An urgent abdominal ultrasound revealed a distended gallbladder laden with biliary sludge and a 5 × 5 mm gallstone, alongside normal bile ducts and a confirmed enlarged spleen. This constellation of findings established a diagnosis of obstructive choledocholithiasis complicated by biliary pancreatitis and splenomegaly.
Rapid Escalation and Surgical Intervention
Within 48 hours of admission, the young patient’s condition deteriorated precipitously, progressing to acute biliary pancreatitis. Laboratory markers soared, showing dramatic spikes in transaminases, pancreatic enzymes, and total bilirubin—predominantly driven by the direct bilirubin fraction.
A repeat ultrasound exposed an obstruction of the distal common bile duct, trapped at the convergence of the pancreatic duct. Confronted with this acute surgical emergency, the medical team executed an endoscopic retrograde cholangiopancreatography (ERCP) combined with a sphincterotomy and successful stone extraction.
Following a magnetic resonance cholangiopancreatography (MRCP) to meticulously map out her biliary tree, the patient underwent an elective laparoscopic cholecystectomy three days later to definitively remove the diseased gallbladder.
Unmasking the Culprit: Hereditary Spherocytosis
While the acute surgical crisis was resolved, the convergence of gallstones, splenomegaly, and initial signs of hemolysis prompted the medical team to request an immediate hematologic evaluation.
Comprehensive blood work conducted after the acute phase resolved confirmed persistent markers of chronic hemolysis:
- Elevated indirect bilirubin and lactate dehydrogenase (LDH) levels.
- Depleted haptoglobin.
- A striking reticulocyte count of 5.93% (absolute count of 226.52 × 10⁹/L).
A peripheral blood smear revealed significant anisopoikilocytosis characterized by the presence of spherocytes and occasional elliptocytes, alongside an increased red cell distribution width (RDW). Immune-mediated hemolysis, hemoglobinopathies, and standard red blood cell enzymatic defects were systematically ruled out through rigorous testing.
Ultimately, functional testing of red blood cell membrane integrity—specifically the eosin-5-maleimide (EMA) binding test and osmotic fragility testing—confirmed a definitive diagnosis of hereditary spherocytosis. Further protein analysis verified an underlying spectrin deficiency. Because neither parent displayed clinical or laboratory markers of the condition, geneticists concluded that the patient’s disease was a de novo (spontaneous) mutation.
Supporting Context & Metrics: The Broader Landscape of Pediatric Cholelithiasis
To understand why this case is clinically transformative, one must examine the broader epidemiological shifts surrounding pediatric gallstone disease.
Over the past two decades, medical literature has documented a steady climb in the incidence of pediatric cholelithiasis, accompanied by a parallel rise in pediatric cholecystectomies. This trend has been overwhelmingly propelled by two factors:
- The global rise in childhood obesity.
- The widespread, routine use of abdominal ultrasonography, which frequently uncovers asymptomatic gallstones incidentally.
In stark contrast, gallstones secondary to chronic hematologic disorders have remained relatively stable, representing less than 20% (typically 5% to 20%) of all pediatric presentations. Because this subgroup is vastly outnumbered by metabolic cases, clinicians often fail to look beneath the surface.
The Mechanism of Pigment Gallstones
Chronic hemolysis—the ongoing, premature destruction of red blood cells—results in a massive, continuous turnover of hemoglobin and, consequently, bilirubin. This excess bilirubin floods the biliary system, where it readily precipitates with calcium to form calcium bilirubinate pigment gallstones.
While severe congenital anemias like sickle cell disease or major thalassemia typically present loudly in infancy or early childhood, milder phenotypes often fly under the radar. Conditions such as non-transfusion-dependent thalassemia, complex compound heterozygosities, or homozygous hemoglobin C and E variants may remain entirely subclinical until adolescence or adulthood. When these patients present with their very first bout of biliary colic, the underlying hematologic disease is frequently missed.
Clinical Parameters at a Glance
The following data tables, adapted from the clinical findings, illustrate the subtle nature of hematological indices during acute presentation versus steady-state recovery.
Table 1: Initial Emergency Department Versus Peak Hospitalization Values
- White Blood Cells (WBC): 11.36 × 10⁹/L (Range: 5.00–14.00)
- Red Blood Cells (RBC): 3.76 × 10¹²/L (Range: 4.00–5.00)
- Hemoglobin (Hb): 12.3 g/dL (Range: 12.0–16.0) — Deceptively normal on initial presentation.
- Total Bilirubin: Spiked from 7.9 mg/dL up to 19.6 mg/dL during hospitalization (Range: 0.2–1.2).
- Lactate Dehydrogenase (LDH): Spiked from 315 U/L up to 480 U/L (Range: 120–300).
- Haptoglobin: Depleted to 0.2 g/L (Range: 0.3–2.0).
Table 2: Steady-State Hemolysis Markers (Post-Resolution)
- Red Cell Distribution Width (RDW): Elevated at 22.2% (Range: 10.0–16.0) — A key red flag indicating cellular variation.
- Absolute Reticulocyte Count: 226.52 × 10⁹/L — Reflecting active bone marrow compensation for destroyed red cells.
Official Guidelines and the New Diagnostic Flowchart
The authors of the Frontiers in Hematology report emphasize that standard laboratory evaluations can easily mislead attending physicians. A cursory glance at a normal hemoglobin level can falsely reassure a clinician, leaving an underlying hemolytic anemia completely unaddressed. This oversight exposes patients to recurrent complications, inadequate monitoring, and missed therapeutic opportunities.
To bridge this clinical gap, the research team has developed a comprehensive, two-section diagnostic flowchart designed for seamless integration into daily medical practice:
- For General Practitioners and Pediatricians: The first section outlines primary warning signs—such as unexplained splenomegaly, elevated indirect bilirubin, high LDH, low haptoglobin, and elevated RDW—to help non-hematologists identify mild congenital hemolytic anemias that present initially as gallbladder pathology.
- For Hematologists: The second section establishes a rigorous, stepwise diagnostic pathway. It incorporates the Direct Antiglobulin Test (DAT) early in the workup to differentiate immune-mediated anemias from congenital defects, while reserving invasive bone marrow assessments strictly for complex or uncertain diagnoses.
By standardizing this approach, the medical community can move away from reactive treatment toward proactive, coordinated care.
Future Outlook: A Call for Systematic Hematological Screening
The management of pediatric cholelithiasis in the shadow of chronic hemolysis demands a paradigm shift. Moving forward, pediatricians, pediatric surgeons, and gastroenterologists must adopt a collaborative, multidisciplinary model.
The authors argue strongly that systematic hematological screening should no longer be an afterthought reserved for obvious cases. Instead, a comprehensive panel—including a complete blood count with red blood cell indices, reticulocyte counts, peripheral blood smears, LDH, haptoglobin, bilirubin fractions, and the Direct Antiglobulin Test—should be standard operating procedure during the initial assessment of pediatric gallstone disease, particularly when complicated by pancreatitis, choledocholithiasis, or splenomegaly.
By integrating these diagnostic safeguards into routine pediatric care, clinicians can catch silent hemolytic disorders before they trigger acute surgical emergencies, ensuring optimal long-term health outcomes for a vulnerable patient population.
